- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pancreatic Adenocarcinoma Resectable in South Africa
Total 990 results
-
BayerCompletedCarcinoma, HepatocellularBelgium, Italy, Spain, Canada, Switzerland, Germany, Greece, Russian Federation, France, United States, United Kingdom, Chile, New Zealand, Australia, Romania, Bulgaria, Croatia, Israel, Peru, Poland, Mexico, Brazil, Argentina
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaUnited States, Australia, Brazil, Chile, China, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Proteostasis Therapeutics, Inc.CompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, Germany, Switzerland, Israel, Netherlands, Belgium, Italy, United Kingdom, France
-
BayerCompletedCarcinoma, Renal CellItaly, France, Germany, United Kingdom, Poland
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, France, United Kingdom, Germany, Czech Republic
-
University of IowaPatient-Centered Outcomes Research Institute; Medical University of South Carolina and other collaboratorsEnrolling by invitationNeuroendocrine Tumors | Neuroendocrine Carcinoma | Lung Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorUnited States
-
PfizerCompletedCarcinoma, Renal CellUnited States, Canada, Spain, Australia, Germany, Italy, Russian Federation, Brazil, France, United Kingdom, Poland
-
NRG OncologyNational Cancer Institute (NCI)CompletedFallopian Tube Carcinoma | Endometrial Serous Adenocarcinoma | Ovarian Carcinoma | Malignant Female Reproductive System Neoplasm | Primary Peritoneal Carcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA... and other conditionsUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, Germany, United Kingdom
-
ProQR TherapeuticsEuropean CommissionCompletedCystic FibrosisUnited States, Spain, United Kingdom, Germany, Italy, Belgium, Canada, Czechia, Denmark, France
-
Eisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Spain, United Kingdom, Australia, Sweden, Italy, Austria, Germany, Portugal, Russian Federation
-
Oregon Health and Science UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingPancreatitis | Pancreatitis, Acute | Pancreas Divisum | Pancreatitis Idiopathic | Pancreas InflamedUnited States, Canada, Netherlands
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Korea, Republic of, United Kingdom, Canada, China, Hong Kong, Taiwan, Australia, Italy, Spain, Czechia, Japan, Singapore, France, Germany, Poland, Russian Federation
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Endometrioid Adenocarcinoma | Stage I Uterine Corpus Cancer AJCC v8 | Stage II Uterine Corpus Cancer AJCC v8United States, Puerto Rico
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Canada, Czech Republic, Ireland, Australia
-
Humanigen, Inc.CompletedCystic FibrosisUnited States, Australia, Israel, New Zealand
-
AmgenTerminatedStomach NeoplasmsBelgium, France, Italy, Spain, Czechia, Poland, United States, Korea, Republic of, Russian Federation, Canada, United Kingdom, Australia, Austria, Germany, Hungary, Greece, Peru, Chile
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaUnited States, Canada, Belgium, Germany, Israel, Korea, Republic of, Spain, Australia, Austria, Brazil, France, Italy, Japan, Portugal, Taiwan, Romania, Bulgaria, Czech Republic, Finland, Hong Kong, Hungary, Netherlands, Norway, Phili... and more
-
PfizerCompletedRenal Cell CarcinomaFrance, Belgium, Hungary, Taiwan, United States, Australia, Spain, Hong Kong, Malaysia, Serbia, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Germany, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation and more
-
Novartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States, Singapore, France, United Kingdom
-
Proteostasis Therapeutics, Inc.CompletedHealthy Volunteer - Complete | Cystic Fibrosis - CompleteUnited States, Belgium, United Kingdom, France, Germany, Canada, Denmark, New Zealand, Australia
-
PfizerCompletedRenal Cell CarcinomaUnited States, Australia, Canada, Spain, France, Italy, Korea, Republic of, Denmark, Germany, United Kingdom, Singapore, Netherlands, Austria, Sweden, Chile, Argentina, China, Finland, Hungary, Switzerland
-
Vertex Pharmaceuticals IncorporatedEnrolling by invitationCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedStudy of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation (ENVISION)Cystic FibrosisUnited States, Australia, Canada, France, Germany, Ireland, United Kingdom
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Small Cell Squamous Carcinoma | Recurrent Lung Non-Small Cell Carcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Recurrent Lung Adenocarcinoma | Loss of Heterozygosity | Recurrent... and other conditionsUnited States
-
BayerCompletedCarcinoma, HepatocellularJapan, China, Slovakia, Croatia, France, Hungary, Indonesia, Korea, Republic of, Malaysia, Singapore, Spain, Sweden, Thailand, Philippines, Colombia, Czech Republic, Hong Kong, Italy, Kazakhstan, Mexico, Romania, Russian Federation, Ukrain... and more
-
Bristol-Myers SquibbCompleted
-
Savara Inc.CompletedCystic Fibrosis | MRSAUnited States, Canada
-
AbbottCompleted
-
University of Alabama at BirminghamCystic Fibrosis FoundationCompleted
-
Hoosier Cancer Research NetworkBionomics LimitedCompletedRenal Cell CarcinomaUnited States, Australia, Singapore
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast CarcinomaUnited States
-
Proteostasis Therapeutics, Inc.CompletedCystic FibrosisUnited States, Canada, France, Denmark, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal CancerUnited States, Canada
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
Parion SciencesVertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationTerminated
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IV Fallopian Tube Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IV Primary Peritoneal Cancer AJCC v8 | Stage II Fallopian Tube Cancer AJCC v8 | Stage II Ovarian... and other conditionsUnited States, Canada, Korea, Republic of, Puerto Rico, Ireland
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Canada, Denmark, Poland, Switzerland
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States, United Kingdom
-
Gilead SciencesCompleted
-
ExelixisCompletedHepatocellular CarcinomaBelgium, Hong Kong, Korea, Republic of, Canada, France, Taiwan, United States, Germany, Spain, United Kingdom, Singapore, Australia, Italy, Netherlands, Poland, Turkey, Ireland, New Zealand, Romania
-
National Cancer Institute (NCI)SuspendedStage III Rectal Cancer AJCC v8 | Locally Advanced Rectal Adenocarcinoma | Stage II Rectal Cancer AJCC v8United States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous for the F508del CFTR MutationUnited States, France, Spain, Belgium, Canada, Austria, Australia, Germany, United Kingdom, Denmark
-
Bristol-Myers SquibbCompletedHepato Cellular Carcinoma (HCC)United States, Argentina, Australia, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Poland, Puerto Rico, Russian Federation, South Africa, Spain, Sweden, ... and more
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingCarcinoma, HepatocellularUnited States, Canada, Korea, Republic of, Taiwan, China, Puerto Rico, Japan, New Zealand, Belgium, Brazil, Spain, Germany, Poland, Thailand, Singapore, France, Turkey, Italy, United Kingdom, Mexico, Côte D'Ivoire, Hong Kong, Nigeria, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in SituUnited States